Cardiovascular benefit of cholesterol-lowering therapy: does improved endothelial vasodilator function matter?
Cannon
R O
RO
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001120:Arginine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology*; D015914:Estrogen Replacement Therapy; D006801:Humans; D017202:Myocardial Ischemia / Q000517:prevention & control; D014810:Vitamin E / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D014810:Vitamin E; D001120:Arginine